Published

AbbVie (NYSE:ABBV) Releases Q3 2024 Earnings Guidance

Summary by defenseworld.net
AbbVie (NYSE:ABBV – Get Free Report) issued an update on its third quarter 2024 earnings guidance on Thursday morning. The company provided earnings per share guidance of 2.920-2.960 for the period, compared to the consensus earnings per share estimate of 2.950. The company issued revenue guidance of -. AbbVie also updated its FY 2024 guidance to 10.710-10.910 EPS. AbbVie Stock Performance Shares of ABBV stock traded down $1.44 during trading ho…
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 50% of the sources are Center, 50% of the sources lean Right
50% Center
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Sources are mostly out of (0)

You have read out of your 5 free daily articles.

Join us as a member to unlock exclusive access to diverse content.